This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

The objective of this review is to determine the effects (benefits and harms) of Suxiao jiuxin wan (in monotherapy or in combination with other antianginal therapies compared to placebo or other anti‐anginal drugs) in the treatment of angina pectoris.